Literature DB >> 3469844

Flow cytometric analysis and cytopathology of body cavity fluids.

K J Stonesifer, J H Xiang, E J Wilkinson, N A Benson, R C Braylan.   

Abstract

A total of 75 samples of body cavity fluids from 71 patients were analyzed by both flow cytometry (FCM), to detect cells with an abnormal DNA content (aneuploidy), and by conventional cytopathology. Samples included 27 pleural fluids, 35 peritoneal fluids, 11 peritoneal washings and 2 pericardial fluids. For cytologic examination, the samples were prepared using standard techniques. Samples for FCM analysis were centrifuged and exposed to a hypotonic solution containing detergent and propidium iodide, a DNA intercalating fluorescent stain. Aneuploidy as well as cytologic malignancy were found in 17 samples. Forty-seven samples had normal DNA histograms by FCM and were also cytologically negative. Four samples suspicious by cytology but normal by FCM were from patients with renal-cell carcinoma (two samples from the same patient), endometrial adenocarcinoma without metastasis and chronic lymphocytic leukemia. Three samples abnormal by FCM but negative by cytology were from patients with ovarian cystadenoma, cirrhosis and uterine leiomyoma. FCM showed aneuploidy in four cytologically negative samples from patients with histologically proven malignancy (lymphoma, colonic adenocarcinoma, cervical squamous cell carcinoma, and endometrial adenosquamous carcinoma). Based on these results, FCM analysis combined with conventional cytopathology yielded 100% sensitivity, 100% predictive value of a negative result and 94% specificity. This rapid and quantitative FCM analysis of body cavity fluids can be a very useful adjunct to conventional diagnostic cytopathology.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3469844

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  4 in total

1.  Flow cytometric analysis of pulmonary fluids and cells for the detection of malignancies.

Authors:  J E Fuhr; A A Kattine; T A Sullivan; H S Nelson
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

2.  Comparison of nucleolar organiser regions and DNA flow cytometry in the evaluation of pleural effusion.

Authors:  M S Huang; M S Tsai; J J Hwang; T H Wang
Journal:  Thorax       Date:  1994-11       Impact factor: 9.139

3.  FANCG is phosphorylated at serines 383 and 387 during mitosis.

Authors:  Jun Mi; Fengyu Qiao; James B Wilson; Anthony A High; Melanie J Schroeder; Peter T Stukenberg; Amy Moss; Jeffrey Shabanowitz; Donald F Hunt; Nigel J Jones; Gary M Kupfer
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

4.  Value of DNA analysis in addition to cytological testing in the diagnosis of malignant pleural effusions.

Authors:  F Rodríguez de Castro; T Molero; O Acosta; G Julià-Serdà; J Caminero; P Cabrera; T Carrillo
Journal:  Thorax       Date:  1994-07       Impact factor: 9.139

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.